Shanghai INT Medical Instruments Co., Ltd. (INT Medical) announced the successful completion of its H-share full-circulation plan. On 3 June 2026, 71.79 million domestic shares were converted into H shares, raising the total number of H shares to 211.20 million. Trading in the newly converted shares will begin on the Hong Kong Stock Exchange at 09:00 on 4 June 2026.
Before the conversion, INT Medical’s share structure comprised 139.41 million H shares (66.01%) and 71.79 million domestic shares (33.99%). Following the transaction, H shares account for 100% of the 211.20 million total shares outstanding, eliminating the domestic-share class entirely.
The company reiterated that shareholders and potential investors should exercise caution when dealing in INT Medical’s securities.
Comments